B7-H4

B7-H4 분자 정보

영어 이름V-set domain-containing T-cell activation inhibitor 1시판 약물 수0
임상 약물 수11표적 별명V-Set Domain-Containing T-Cell Activation Inhibitor 1,Immune costimulatory protein B7-H4,B7h.5,B7 homolog 4,T-cell costimulatory molecule B7x,V-Set Domain Containing T Cell Activation Inhibitor 1,B7X,B7 Family Member, H4,T Cell Costimulatory Molecule B7x,B7S1,B7 Superfamily Member 1,VCTN1,PRO1291,FLJ22418,B7H4,B7-H4,Protein B7S1
최고 연구 개발 단계Phase 3 Clinical
영어 이름V-set domain-containing T-cell activation inhibitor 1
표적 별명V-Set Domain-Containing T-Cell Activation Inhibitor 1,Immune costimulatory protein B7-H4,B7h.5,B7 homolog 4,T-cell costimulatory molecule B7x,V-Set Domain Containing T Cell Activation Inhibitor 1,B7X,B7 Family Member, H4,T Cell Costimulatory Molecule B7x,B7S1,B7 Superfamily Member 1,VCTN1,PRO1291,FLJ22418,B7H4,B7-H4,Protein B7S1
시판 약물 수0
임상 약물 수11
최고 연구 개발 단계Phase 3 Clinical

B7-H4 제품 목록

  • 속성

    Protein (11)Cell (1)

  • 제품 라이브러리

    온라인 (12)

  • Human (5)Mouse (3)Cynomolgus / Rhesus macaque (2)Rat (1)Canine (1)

  • 태그

    His Tag (7)His Tag & Avi Tag (3)Fc Tag (1)- (1)

  • 마커

    Unconjugated (6)Biotin-labeled (4)Azide Labeled (1)- (1)

B7-H4분자 배경

V-set domain-containing T-cell activation inhibitor 1 (VTCN1) is also known as Immune costimulatory protein B7-H4, Protein B7S1, T-cell costimulatory molecule B7x, B7H4, which belongs to the immunoglobulin superfamily and BTN/MOG family. VTCN1 contains two Ig-like V-type (immunoglobulin-like) domains. The expression of VTCN1 is up-regulated by IL6 and IL10 and is inhibited by GM-CSF and IL4 on antigen-presenting cells (APCs). VTCN1 / B7-H4 negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. VTCN1 involved in promoting epithelial cell transformation.

B7-H4분자 별명

B7-H4,VTCN1,B7S1,B7h.5

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Puxitatug SamrotecanAZD8205; AZD-8205Phase 3 ClinicalAstrazeneca PlcBiliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
상세
Mocertatug RezetecanHS-20089; GSK-5733584; GSK5733584Phase 3 ClinicalShanghai Hansoh Biomedical Co LtdBreast Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
ABL-103ABL-103Phase 2 ClinicalAbl Bio Inc, Handok IncSolid tumours
상세
MHB-009CMHB-009C; MHB009CPhase 2 ClinicalMinghui Pharmaceutical (Hangzhou) Co LtdSolid tumours
상세
GEN-1047GEN-1047Phase 2 ClinicalGenmab A/SEndometrial Neoplasms
상세
DB-1312BG-C9074; DB-1312Phase 1 ClinicalDuality Biologics (Suzhou) Co LtdSolid tumours
상세
LNCB-74LNCB-74; LNCB74; LCB41APhase 1 ClinicalLigaChem Biosciences Inc, Nextcure IncBiliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours
상세
XKH-002XKH-002; XKH002Phase 1 ClinicalBeijing Kanova Biomedical Technology Co Ltd, Zhejiang Kanova Biopharmaceutical Co LtdNeoplasms; Solid tumours
상세
Felmetatug vedotinSGN-B7H4V; PF-08046048; SGN-B-7H-4V; SGNB-7H4V; SGNB-7H-4VPhase 1 ClinicalSeagen IncBreast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
상세
Emiltatug LedadotinXMT-1660Phase 1 ClinicalMersana Therapeutics IncAbdominal Neoplasms; Breast Neoplasms; Carcinoma, Adenoid Cystic; Endometrial Neoplasms; Fallopian Tube Neoplasms; Neoplasms; Ovarian Neoplasms; Triple Negative Breast Neoplasms
상세
HBM-7008HBM7008; HBM-7008; R-7008; CLN-418Phase 1 ClinicalHarbour BiomedSolid tumours
상세

제품 리뷰

  • 1***12019-11-16
    5사람들이 좋아합니다
    We purchased total of 600ug of this biotin-labeled antigen for liquid phase panning and antibody screening of affinity maturation. This antigen has good stability, high quality, and high repeatability for each experiment. Using this antigen, we screened high-affinity antibodies against this target. And using this antigen for screening of affinity maturation, we obtained antibodies with 10-times increased affinity. I highly recommended this product.
  • 분자 정보
  • 제품 목록
  • 제품 리뷰
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호